Selective potentiation of lometrexol growth inhibition by dipyridamole through cell-specific inhibition of hypoxanthine salvage

British Journal of Cancer

Volumn 76, Issue 10, 1997, Pages 1300-1307

  Turner, R N ^a,d   Aherne, G W ^b   Curtin, N J ^a,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Dipyridamole; Hypoxanthine transport; Lometrexol; Selective potentiation

Indexed keywords

DEOXYGUANOSINE TRIPHOSPHATE; DIPYRIDAMOLE; FOLIC ACID ANTAGONIST; HYPOXANTHINE; LOMETREXOL;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL STRAIN HT29; CELL TRANSPORT; CHO CELL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG SENSITIVITY; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; LEUKEMIA L 1210; MOUSE; NONHUMAN; NUCLEOSIDE TRANSPORT; PHENOTYPE; PRIORITY JOURNAL; PURINE METABOLISM; PURINE SYNTHESIS;

EID: 0030657927     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.552     Document Type: Article

References (40)

1. Aherne W, Hardeastle A, Kelland L and Jackman A (1995) The measurement of deoxynucleotide (dNTP) pools by radioimmunoassay (RIA). In Purine and Pyrimidine Metabolism in Man. VIII. Sahota A and Taylor M (eds), pp. 801 804 Plenum Press: New York
2. Beardsley GP, Moroson BA, Taylor EC and Moran RG (1989) A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrabydrofolate is a potent inhibitor of de novo purine synthesis. J Biol Chem 254: 328-333
3. Belt JA (1983) Heterogencity of nucleoside transport in mammalian cells. Mol Pharmacol 24: 479-484
4. Belt JA, Marina NM. Phelps DA and Crawford CR (1993) Nucleoside transport in normal and malignant cells. Advan Enzyme Regul 33: 235-252
5. Benz C and Cadman E (1991) Biochemical alterations during unperturbed suspension growth of L1210 cells. Cancer Res 41: 157-163
6. Bokkerink JPM. De Abreu RA, Bakker MAH, Hulscher TW, Van Baal JM and De Vaan GAM (1986) Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in Molt-4 malignant human T-lymphoblasts. Biochem Pharmacol 35: 3557-3564
7. Chan TCK and Howell SB (1990) Role of hypoxanthine and thymidine in determining methotrexate plus dipyridamole cytotoxicity. Eur J Cancer 26: 907-911
8. Cohen JD, Robins HI, Katz TB, Miller EM, Kuzminsky SR, and Javid MJ (1993) Deoxribonucleoside triphosphate pools and chemosensitisation in human T-cell leukaemia. Leuk Res 17: 167-174
9. Curtin NJ, Harris AL and Aherne GW (1991) Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation. DNA damage and growth inhibition following exposure to CB3717 and dipyridamole. Cancer Res 51: 2346-2352
10. Domin BA, Mahony WB and Zimmerman TP (1988) Purine nucleobase transport in human erythrocytes. J Biol Chem 263: 9276-9284
11. Erba E, Sen S, Sessa C, Vikhanskaya FL and D'Incalci (1994) Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of drug activity by folic or folinic acid. Br J Cancer 69: 205-211
12. Fox M, Boyle JM and Kinsella AR (1991) Nucleoside salvage and resistance to antimetabolite anticancer agents. Br J Cancer 64: 428-436
13. Garrett C and Santi DV (1979) A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Anal Biochem 99: 268-273
14. Goel R and Howell SB (1991) Modulation of the activity of cancer chemotherapeutic agents by dipyridamole. In New Drugs. Concepts and Results in Cancer Chomotherapy. FM Muggia (ed.) pp. 19-44. Kluwer Academic Press: Boston MA
15. 1). J Biol Chem 268: 20085- 20090
16. Halloran MJ and Parker CW (1966) The preparation of nucleotides protein conjugates: carbodiimides as coupling: agents. J Immunol 96: 373-378
17. Janowska-Wieczorek A and Cass CE (1987) Pharmacologic manipulation to reverse drug resistance and protect haematopoietic stem cells during purging. In Autologous Bone Marrow Transplantation. Dicke K, Spitzer G and Jagannath F (eds). pp. 177-185. Univ Texas: Houston
18. Kinsella AR and Harran MS (1991) Decreasing sensitivity to cytotoxic agents parallels increasing tumorigenicity in human fibroblasts. Cancer Res 51: 1855-1859
19. Kraopp M and Marz R (1995) Membrane transport of nucleobases: interaction with inhibitors. Gen Pharmacol 26: 1185-1198
20. Kwok JBJ and Tattersall MHN (1991) Inhibition of 2-desamino-2-methyl-10-propargyl-5,8-dideazatetrahydrofolic acid cytotoxicity by 5.10-dideazatetrahydrofolate in L1210 cells with decrease in DNA fragmentation and deoxyadenosine triphosphate pools. Biochem Pharmacol 42: 507-513
21. Marina NM and Belt JA (1991) Effect of nucleoside transport inhibitors on thymidine salvage and the toxicity of nucleoside analogues in mouse bone marrow granulocyte macrophage progenitor cells. Cancer Commun 3: 367-372
22. Mattano SS. Palella TD and Mitchell BS (1990) Mutations induced at the hypoxanthine-guanine phosphoribosyltransferase locus of human T-lymphoblasts by perturbations of purine deoxyribonucleoside triphosphate pools. Cancer Res 50: 4566-4571
23. Nelson R, Butler F, Dugan Jr W, Davisland C, Stone M and Dyke R (1990) Phase I study of Lometrexol (Dideazatetrahydrofolic acid; DDATHF). Proc Am Soc Clin Oncol 9: 76
24. Paganini O, Sessa C, Dejong J, Kem H, Hatty S, Schmitt H, and Cavalli F (1992) Phase I study of lometrexol (DDATHIF) given in combination with leucovorin. Proc Am Soc Clin Oncol 11: 109
25. Piall EM, Aherne GW and Marks V (1986) The quantitative determination of 2'-deoxycytidine-5'-triphosphate in cell extracts by radioimmunoassay. Anal Biochem 154: 276-281
26. Piall EM, Curtin NJ, Aherne GW, Harris AL and Marks V (1989) The quantitation by radioimmunoassay of 2'-deoxyuridine-5'-triphosphate in extracts of thymidylate synthase inhibited cells. Annl Biochem 177: 347-352
27. Pizzorno G, Moroson BA, Cashmore AR and Beardsley GP (1991) (6R)-5.10-dideaza-5,6,7,8-tetrahydrofolic acid effects on nucleotide metabolism in CCRF-CEM human T-lymphoblast leukemia cells. Cancer Res 51: 2291-2295
28. Plagemann PGW and Wohlhueter RM (1984a) Hypoxanthine transport in mammalian cells: cell type-specific differences in sensitivity to inhibition by dipyridamole and uridine. J Memb Biol 81: 255-262
29. Plagemann PGW and Wohlhueter RM (1984b) Nucleoside transport in cultured mammalian cells. Multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxamhine. Biochim Biophys Acta 773: 39-52
30. Plagemann PGW, Wohlhueter RM and Woffendin C (1988) Nucleoside and nucleobase transport in animal cells. Biochim Biophys Acta 947: 405-443
31. Ray M, Muggia F, Martin T, Leichman CG, Grunberg S, Nelson RL, Dyke R and Moran R (1993) Phase I study of (6R)-5, 10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis. J Natl Cancer Inst 85: 1154-1159
32. Ross DD, Akman SA, Schrecker AW and Bachur NR (1981) Effects of deoxynucleosides on cultured human leukaemia cell growth and deoxynucleotide pools. Cancer Res 41: 4493-4498
33. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112
34. Slaughter RS and Barnes EM Jr (1979) Hypoxanthine transport by Chinese hamster lung fibroblasts: Kinetics and inhibition by nucleosides. Arch Biochem Biophys 197: 349-355
35. Sokoloski JA, Pizzorno G. Beardsley GP and Sartorelli AC (1993) Evidence for a relationship between intracellular GTP levels and the induction of HL-60 leukemia cell differentiation by 5.10-dideazatetrahydrofolic acid (DDATHF). Oncol Res 5: 293-299
36. Spyrou G and Reichard P (1988) Dynamics of the thymidine triphosphate pool during the cell cycle of synchronised 3T3 mouse fibroblasts. Mutat Res 200: 37-43
37. Tattersall MHN. Slowiaczek P and De Fazio A (1983) Regional variation in human extracellular purine levels. J Lab Clin Med 102: 411-420
38. Tyrsted G (1975) The pool size of deoxyguanosine 5'-triphosphate and deoxycylidine 5'-triphosphate in phytohemagglutinin-stimulated and non-stimulated human lymphocytes. Exp Cell Res 91: 429-440
39. Van Mouweric TJ, Pangallo C, Willson JKV and Fischer PH (1987) Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole. Biochem Pharmacol 36: 809-814
40. Young C, Currie V, Baltzer L, Trochanowski B, Eton O, Dyke R and Bowsher R (1990) Phase I and clinical pharmacologic study of LY264618 and 5.10-dideazatetrahydrofolate. Proc Am Assoc Cancer Res 31: 177